Oncology and oncology-support specialty pharmaceutical company Dara BioSciences said it has launched a new product for treating skin irritation and burns associated with radiation therapy.
Bionect helps radiation therapy patients deal with radiodermatitis, an effect of radiotherapy. In a double-blind, randomized, placebo-controlled clinical trial, Bionect was shown to help resolve radiation-induced inflammation and also to postpone the first signs of acute epithelitis, according to Dara.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
